AVAX And TRX Stagnate As their Holders Switch to Nexchain: Top Crypto Presale to Buy?

來源 Cryptopolitan

Altcoin whales often rotate when tokens stall in growth, leading investors to explore crypto presale projects. This shift has become evident as AVAX and TRX holders look for alternatives among the top crypto presales.

Nexchain has emerged as a leading option, positioning itself as one of the best crypto presales to buy right now. With its AI-driven blockchain design and strong fundraising progress, it is gaining momentum while other assets remain range-bound.

Recent updates include a testnet launch last month, a new roadmap released on September 5, and an upcoming Whitepaper v2.0 and documentation update on September 15.

Nexchain AI Layer 1 Blockchain: Top Crypto Presale

Nexchain introduces itself as the world’s first blockchain fully built on AI. Unlike traditional platforms, it integrates machine learning into its core, which allows the network to optimize performance and manage resources more effectively. This foundation makes Nexchain one of the top presale crypto tokens attracting early whale interest.

At Stage 27 of its new crypto token presale, NEX is priced at $0.108. To date, more than $10,154,674 has been raised out of the $11,025,000 target, signaling steady participation across retail and institutional circles. Many investors scanning the crypto presale list see Nexchain as one of the best crypto presales to buy right now.

Key progress marks have been made in recent weeks. The testnet went live last month, giving the community its first hands-on view. On September 5, the updated roadmap was released, setting milestones for development. Whitepaper v2.0 and updated documentation will follow on September 15.

Between September 5 and 15, a 50% bonus is available for early participants using the code wp50. With a focus on scalability, energy efficiency, and cross-chain interoperability, Nexchain continues to strengthen its place in the presale cryptocurrency sector.

Avalanche (AVAX) Navigates Between $26 and $29

Avalanche (AVAX) has entered a consolidation zone, trading between $26 and $29. This sideways range highlights a pause in directional momentum, though activity on the network has seen a clear increase.

Last week alone, the Avalanche blockchain processed nearly 12 million transactions, representing a 66% rise in throughput. This growth suggests that both retail and institutional activity are returning, even while price action remains within its channel.

For those tracking crypto coins on presale and established assets, AVAX offers a contrast. While its underlying adoption expands, the price holds steady, prompting some holders to diversify into crypto presales like Nexchain.

TRX Market Activity Remains Steady Around $0.34

Tron (TRX) has been trading within a narrow range of $0.324 to $0.344, showing a big movement in recent days. Market activity highlights steady but uneventful conditions. Daily trading volume has been fluctuating between $600 million and $800 million, while market capitalization remains close to $32 billion.

The token reached an intraday high of $0.333 and a low of $0.326, reinforcing the consolidation outlook. Beyond the technicals, Tron made headlines when Tron Inc. added 312.5 million TRX, valued around $110 million, to its treasury on September 5. This move lifted total holdings to $220 million.

For many investors balancing between stable assets and opportunities from crypto presales, the contrast is clear. While TRX continues to hold its ground, new crypto presales like Nexchain provide active engagement and growing participation.

Presale Crypto Momentum: Nexchain, and the Investor Shift

Altcoin markets often display cycles where established tokens consolidate, and attention shifts to emerging projects. This rotation is evident as holders of AVAX and TRX explore presale crypto tokens for higher engagement.

Nexchain stands out by combining technical strength with consistent development updates. With its AI-first design, active testnet, and upcoming Whitepaper v2.0, it positions itself within the most notable crypto presales 2025. Investors seeking to buy presale crypto now view it alongside other presale cryptocurrency opportunities shaping this year’s market.

Learn more about the Nexchain presale here:

Website: nexchain.ai/ 

X: x.com/nexchain_ai 

Telegram: t.me/nexchain_ai 

LinkedIn: www.linkedin.com/company/nexchainai/ 

免責聲明:僅供參考。 過去的表現並不預示未來的結果。
placeholder
黃金七連漲終結!是上車機會還是牛市拐點?​2025年9月4日,瘋狂上漲的黃金終於「喘了口氣」——國際金價在連續七日創新高後回檔0.38%,收報3545.78美元/盎司。很多投資人一邊糾結是不是該獲利了結,一邊又怕錯過後續行情。
作者  投資-槓把子
9 月 05 日 週五
​2025年9月4日,瘋狂上漲的黃金終於「喘了口氣」——國際金價在連續七日創新高後回檔0.38%,收報3545.78美元/盎司。很多投資人一邊糾結是不是該獲利了結,一邊又怕錯過後續行情。
placeholder
康霈*減重藥遭FDA一拳重擊!股價跳空跌停 賣單高掛上萬張 散戶集體出逃?​投資慧眼Insights-因減肥藥進展受阻,生技股康霈*(6919)今(10)日早盤開盤即跌停鎖死在229.5元,暴跌10%。
作者  投資指南針
昨日 03: 15
​投資慧眼Insights-因減肥藥進展受阻,生技股康霈*(6919)今(10)日早盤開盤即跌停鎖死在229.5元,暴跌10%。
placeholder
康霈*澄清來得太遲!1.5萬張賣單說明一切:一場由減肥藥夢碎引發的踩踏遠未結束生物科技股康霈*(6919)昨日法說會拋出減肥新藥臨床試驗延期半年的消息,儘管公司火速發布聲明強調是"主動選擇推遲",卻難以掩蓋股價一日跌停鎖死、1.5萬張賣單排隊的殘酷現實。這場被市場解讀為"欲蓋彌彰"的澄清,反而揭露了生物科技股過度投機的問題本質。
作者  投資-槓把子
昨日 06: 35
生物科技股康霈*(6919)昨日法說會拋出減肥新藥臨床試驗延期半年的消息,儘管公司火速發布聲明強調是"主動選擇推遲",卻難以掩蓋股價一日跌停鎖死、1.5萬張賣單排隊的殘酷現實。這場被市場解讀為"欲蓋彌彰"的澄清,反而揭露了生物科技股過度投機的問題本質。
placeholder
黃金、白銀繼續衝高,澳新銀行:2025年底金價將漲至3800美元!2025年底,金價有望漲至3800美元,銀價可望漲至50美元。
作者  Tony Chou
昨日 08: 57
2025年底,金價有望漲至3800美元,銀價可望漲至50美元。
placeholder
生技股王殞落! FDA重擊+內部人狂賣,康霈*遭連續兩日跌停康霈*生技新藥研發進程突生變數,引發市場劇烈反應。這家不久前剛被納入台灣五十指數成分股的生技明星企業,在9月9日法說會上宣布,其核心產品減肥注射劑CBL-514的臨床三期試驗將延後約半年收案,導致公司股票連續兩個交易日跌停,市值蒸發400億元,跌停板委賣張數累計超過3萬張。
作者  投資-槓把子
12 小時前
康霈*生技新藥研發進程突生變數,引發市場劇烈反應。這家不久前剛被納入台灣五十指數成分股的生技明星企業,在9月9日法說會上宣布,其核心產品減肥注射劑CBL-514的臨床三期試驗將延後約半年收案,導致公司股票連續兩個交易日跌停,市值蒸發400億元,跌停板委賣張數累計超過3萬張。
goTop
quote